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Purpose. To report a case of successful thrombolysis performed in a patient with an incidental unruptured intracranial aneurysm
and review the literature. Case Report. Patient admitted for ischemic stroke due to left posterior cerebral artery occlusion, with an
incidental right middle cerebral artery aneurysm, who underwent treatment with tissue plasminogen activator (rtPA) resulting in
clinical improvement without complications. Conclusion. The presence of unruptured intracranial aneurysms is considered as a
contraindication to thrombolysis, due to a potentially higher hemorrhagic risk of aneurysm rupture. Patients, otherwise, eligible
for thrombolysis are usually excluded from receiving this emergent treatment, despite its potential benefits. A reevaluation of the
strict exclusion criteria for thrombolysis in acute stroke patients should be considered.
1. Introduction
Therapeutic guidelines for intravenous thrombolysis for
treating hyperacute ischemic stroke are very strict [1]. Evi-
dence of unruptured cerebral aneurysms contraindicates
thrombolysis due to the perceived increase in the risk of
rupture and consequent intracranial hemorrhage as a result
of rtPA administration [1, 2].
2. Case Presentation
A patient was admitted to the emergency room eighty
minutes after the onset of sudden left conjugated ocular
deviation with right homonymous hemianopia, right central
facial palsy and hemiparesis, as well as right hypoesthesia
without neglect.The initialNational Institute ofHealth Stroke
Scale (NIHSS) score was 16 points.
An initial noncontrast-enhanced brain computer tomog-
raphy (CT) study showed a spontaneous hyperdensity on the
P2 segment of the left posterior cerebral artery. There was no
evidence of other major vessel occlusion or signs of intracra-
nial hemorrhage; therefore, recombinant tissue plasminogen
activator (rtPA) was administered intravenously, at a dosage
of 0.9mg/Kg, 92 minutes after the onset of symptoms.
A CT angiogram performed during rtPA perfusion con-
firmed a left posterior cerebral artery occlusion at the P1-
P2 transition and a 7mm saccular aneurysm at the right
sylvian trifurcation was detected (Figure 1). The patient
underwent immediate brain diffusion magnetic resonance
imaging (MRI) and sentinel bleeding due to the fact that
aneurysm rupture was excluded and a left thalamic acute
ischemic lesion was confirmed. After weighing the available
clinical data and the sum of the neuroimaging studies it was
decided to maintain intravenous (IV) thrombolysis.
Following IV thrombolysis, significant clinical improve-
ment occurred, with a NIHSS of 6 points at the 24-hour time
point.
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Figure 1: 7mm saccular aneurysm at the right sylvian trifurcation.
A brain CT performed 24 h after thrombolysis did not
show hemorrhagic complications.
An angiography was performed eight days after throm-
bolysis. This confirmed the presence of a saccular aneurysm
with a diameter of 5mm at the right middle cerebral artery.
Complete aneurysm exclusion was accomplished using a
low-profile visualized intraluminal support (LVIS) stent plus
embolization with coils. There were no complications related
to this procedure.
A brain CT performed before discharge identified a
recent left thalamus-capsular ischemic infarct and signs of
aneurysm embolization.
The patient was discharged scoring 4 in the NIHSS and 2
in the modified Rankin scale.
3. Discussion
Intravenous tissue-type plasminogen activator is the only
Food and Drug Administration approved pharmacological
therapy for patients with an acute ischemic stroke [2].
A clinically important intracranial hemorrhage (ICH)
can develop as an adverse effect of thrombolytic therapy and
is the most feared complication of thrombolysis [3].
Some risk factors for bleeding after the administration of
rtPA have been either documented or proposed. One of the
risks is the presence of unruptured cerebral aneurysms, thus
resulting in this risk being listed as a contraindication.
Theoretically, there is an increased postthrombolysis ICH
risk from aneurysm rupture, as it is known that rtPA alters
vascular permeability as well as the integrity of vascular basal
lamina [4]. However, how significant this risk is has not been
established [5].
The exclusion criterion for performing thrombolysis in
the presence of unruptured cerebral aneurysms was desig-
nated before initial trials, thereby establishing no relation
between the size and location of the aneurysms and lacking
clear definition as an exclusion criterion in many protocols
[6].
The incidences of unruptured cerebral aneurysms and
subarachnoid hemorrhage suggest that most intracranial
aneurysms do not rupture [7]. However, data on aneurysm
prevalence and risk of aneurysm rupture vary according to
study design, study population, aneurysm size and location,
history of previous aneurysm rupture, and the neuroimaging
techniques used for its detection [7, 8]. In patients without
any previous SAH, the annual risk of rupture of small
aneurysms, measuring <10mm, is low (0.5% per year) [9].
Symptomatic aneurysms, aneurysms located in the posterior
circulation, including basilar artery aneurysms, aneurysms
harbored by patients with a previous SAH from a separate
intracranial aneurysm, and aneurysms larger than 10mm,
have a markedly increased risk of rupture [8].
In consideration of prethrombolysis neuroimaging tech-
niques in protocols where a standard CT without contrast
agents is the only exam required, cerebral aneurysms, par-
ticularly unruptured intracranial aneurysms, cannot be ade-
quately excluded, resulting in a subsequent underreporting of
cerebral aneurysms real prevalence [9].
Taking into account the implementation of recent neu-
roimaging techniques, there has been an increase in the inci-
dental discovery of aneurysms in patients, otherwise, eligible
for thrombolysis [5]. The exclusion of an early hemorrhage
from aneurysm rupture is a key point in the decision of
whether or not to continue thrombolysis in these patients.
To date, several cases have been reported of safe IV
administration of rtPA in patients with cerebral aneurysms
which were either previously known or incidentally discov-
ered when undergoing intracranial angiogram (computed
tomography, magnetic resonance, or catheter angiography)
during the first hours after stroke [1, 10].
Nevertheless, a few cases have been described where
cerebral aneurysm rupture with ICH developed after IV
thrombolysis, in one case administered for treatment of myo-
cardial infarction [1] and in two others for ischemic stroke.
Regarding the latter, the stroke was related to a left middle
cerebral artery thromboembolism and thrombolysis resulted
in an anterior communicating artery aneurysm rupture [11].
In another study, CT angiography performed in the setting of
clinical deterioration which followed thrombolysis demon-
strated that a likely left internal carotid artery dissection
with middle cerebral artery thromboembolism had been the
event behind the patient’s initial presentation [12].
Four retrospective cohort studies on this issue have been
conducted in centers with dedicated stroke units, compound-
ing a total of 714 patients who received IV thrombolysis
for acute stroke, 48 of whom had intracranial unruptured
aneurysms. All of these either did not show a significant
difference in the rate of bleeding as a result of rtPA admin-
istration among patients with aneurysms compared to the
rate among those without [5, 13, 14] or failed to establish an
association between the use of thrombolysis and aneurysm
rupture [15].
4. Conclusion
This case report suggests that intravenous rtPA administered
in patients with acute ischemic stroke in the presence of
unruptured cerebral aneurysms may, in selected cases, have
a good benefit-to-risk ratio. Notwithstanding the limited
time frame for acute stroke treatment, the decision to main-
tain thrombolysis in patients with unreported intracranial
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aneurysms must, following a step-by-step approach, con-
sider all available data. This approach allows the expan-
sion and improvement of the use of thrombolysis in these
patients, while safely considering a delayed treatment of the
aneurysms.
Despite some reports in the literature of successful off-
label thrombolysis cases in this group of patients, there may
still be significant underreporting of cases similar to ours
which could contribute to a modification of the current strict
guidelines for acute ischemic stroke [1].
We suggest recording intracranial aneurysms in the
prospective registries of thrombolysis in acute stroke patients.
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